Clinical Trial Update: Prospective Evaluation of Xerava Prophylaxis in Hematological Malignancy Patients With Prolonged Neutropenia [Phase 2]

View source ↗

Summary

This clinical trial update covers a Phase 2 prospective evaluation of Xerava (eravacycline) as prophylaxis for infections in patients with hematologic malignanc…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hematologic Malignancies
• Neutropenia

Drugs mentioned

• XERAVA (eravacycline)

Snippet

Sponsor: West Virginia University | Conditions: Hematological Malignancy, Neutropenia | Phase 2 | Status: RECRUITING